What are you looking for?
The Xen63 gel stent and Preserflo microshunt achieved similar intraocular pressure (IOP)-lowering outcomes and surgical success rates at 12 months in patients undergoing standalone glaucoma surgery with intraoperative mitomycin C, according to a study. However, Xen63 was associated with higher rates of postoperative complications and reoperations. In the analysis of 140 eyes, 65 underwent Xen63... ...
There may be potential interactions between cancer, cancer treatments, and glaucoma risk, according to a study. This systematic review included 44 eligible...
The XEN63 Gel Stent provided sustained intraocular pressure (IOP) reduction and reduced medication use over 3 years in patients with primary open-angle...
A glueless, sutureless pterygium excision technique using a triple-layer dehydrated, decellularized amniotic basement membrane with brief mitomycin-C exposure was associated with 0%...
The Xen63 gel stent and Preserflo microshunt achieved similar intraocular pressure (IOP)-lowering outcomes and surgical success rates at 12 months in patients undergoing standalone glaucoma surgery with intraoperative mitomycin C,...
There may be potential interactions between cancer, cancer treatments, and glaucoma risk, according to a study. This systematic review included 44 eligible studies from an initial pool of 8,103 records....
The XEN63 Gel Stent provided sustained intraocular pressure (IOP) reduction and reduced medication use over 3 years in patients with primary open-angle glaucoma, according to findings from a prospective multicenter...
A glueless, sutureless pterygium excision technique using a triple-layer dehydrated, decellularized amniotic basement membrane with brief mitomycin-C exposure was associated with 0% recurrence and no reported complications at a mean...
Our most-read ophthalmology coverage of 2025 highlights how innovation continues to improve both diagnosis and treatment. From expert perspectives on the evolving therapeutic landscape in age-related macular degeneration to growing...
In the latest episode of The Ophthalmic Project, Mark Dlugoss hosts Nicole Bajic, MD, a comprehensive ophthalmologist and assistant professor at the Cleveland Clinic’s Cole Eye Institute. Dr. Bajic says... ...
Intense pulsed light (IPL) therapy is more effective and safer than conventional medication for treating dry eye syndrome after SMILE surgery, with sustained long-term benefits, while diabetes remains a key...
From novel testing methods to promising new devices and treatments, 2024 explored the latest advancements in glaucoma care that are shaping the future of eye health. 1. Clustered testing approach...
